SUBSCRIBE
SUBSCRIBE
News   Business

Ariad Pharmaceuticals, Inc. to Receive $2.5 Million from Partner Merck & Co., Inc.

August 6, 2008 | 
1 min read
CAMBRIDGE, Mass. (AP) -- Ariad Pharmaceuticals Inc. said Wednesday it will receive a $2.5 million payment from partner Merck & Co. for moving a cancer drug into midstage clinical trials.
Alliances
Merck & Co.
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Biogen Upends 20 Employees After Axing AAV Work
September 30, 2025
 · 
207 min read
 · 
BioSpace Editorial Staff
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Series A
Novo-Backed Crystalys Debuts With $205M to Tackle Gout
September 30, 2025
 · 
2 min read
 · 
Tristan Manalac
Red Businesswoman Silhouette, Black Business People Group Team Concept Vector Illustration
Editorial
GSK CEO Emma Walmsley’s Departure Reseals Pharma’s Glass Ceiling
September 29, 2025
 · 
1 min read
 · 
Annalee Armstrong
GSK CEO Emma Walmsley
C-suite
GSK’s Emma Walmsley, Pharma’s First Woman CEO, Steps Down After 9 Years
September 29, 2025
 · 
4 min read
 · 
Annalee Armstrong